High Cholesterol Levels in Midlife Raises Risk of Late Life Dementia

According to researchers, elevated cholesterol levels in midlife, even levels considered only borderline elevated, significantly increase the risk of Alzheimer's disease and vascular dementia later in life.

The four-decade study of 9,844 men and women found that having high cholesterol in midlife (240 or higher milligrams per deciliter of blood) increases, by 66 percent, the risk for Alzheimer's disease later in life. Even borderline cholesterol levels (200 – 239 mg/dL) in midlife raised risk for late-life vascular dementia by nearly the same amount: 52 percent.

Vascular dementia, the second most common form of dementia after Alzheimer's disease, is a group of dementia syndromes caused by conditions affecting the blood supply to the brain. Scientists are still trying to pinpoint the genetic factors and lifestyle causes for Alzheimer's disease.

By measuring cholesterol levels in 1964 to 1973 based on the 2002 Adult Treatment Panel III guidelines (the current practice standard) when the participants were 40 to 45 years old, then following the participants for 40 years, this study is the largest long-term study with the most diverse population to examine the midlife cholesterol levels and late-life dementia. It is also the first study to look at borderline high cholesterol levels and vascular dementia, rather than just Alzheimer's disease.

"Our study shows that even moderately high cholesterol levels in your 40s puts people at greater risk for Alzheimer's disease and vascular dementia decades later," said the study's senior author. Rachel Whitmer. "Considering that nearly 100 million Americans have either high or borderline cholesterol levels, this is a disturbing finding. The good news here is that what is good for the heart is also good for the mind, and this is an early risk factor for dementia that can be modified and managed by lowering cholesterol through healthy lifestyle changes."

This study adds to other research emphasizing the importance of addressing dementia risk factors in midlife, before an underlying disease or symptoms appear, the researchers said.

"Our findings add to the existing body of evidence on a degree of overlap between two dementia types in terms of risk factors, symptoms and neuropathology," said the study's lead author, Alina Solomon. "Dementia and cardiovascular disease are common major health problems, share several risk factors and often occur simultaneously, interacting with one another. A holistic approach that addresses multiple major health problems simultaneously is needed to effectively manage these disorders."

The study tracked members of Kaiser Permanente's Northern California Medical Group from 1967 to 2007 by using the multiphasic testing records pioneered by Kaiser Permanente founding physician Morris Collen, who is widely regarded worldwide as a health care informatics pioneer. Of the original 9,844 participants, 598 were diagnosed with Alzheimer's disease or vascular dementia between 1994 and 2007, when the participants were between 61 and 88 years old.

This epidemiological study did not examine the mechanism of the link between cholesterol levels and dementia.

This study is part of an ongoing body of research at Kaiser Permanente to better understand the risk and protective factors for dementia. Dr. Whitmer recently authored two dementia-related studies: one that found a larger abdomen in midlife increases risk of late-life dementia, and one that showed that low blood sugar events in elderly patients with type 2 diabetes increase their risk for dementia. Another Kaiser Permanente study, led by Valerie Crooks of Kaiser Permanente in Southern California, found that having a strong social network of friends and family appears to decrease risk for dementia.

Related Articles

Scientists Make Headway in Understanding Alzheimer's

Scientists have discovered that a protein called BAG2 is important for understanding Alzheimer's and may open up new targets for treatment. They are ready to move

Alzheimer's Disease Drug Has No Beneficial Effect

According to a large phase 3, randomized trial, patients with mild Alzheimer disease who received the drug tarenflurbil did not have better outcomes on measures of

Martial Arts Can Be of Benefit to Those With Early Stage Dementia

Those diagnosed with early stage dementia can slow their physical, mental and psychological decline by taking part in therapeutic programs that combine counseling,

Adults Show Poor Dementia Literacy and PTSD Linked to Risk of Dementia

Research reported at the Alzheimer's Association 2009 International Conference on Alzheimer's Disease (ICAD 2009) in Vienna show higher Alzheimer's risk in

New Protein Discovery Could Be Used to Diagnose Alzheimer's Disease

Researchers have discovered a previously unknown substance in spinal fluid that could be used to diagnose Alzheimer's disease. The substance is a beta-amyloid

References:
1. Alina Solomon, et al. Kaiser Permanente News Center.